{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:57:21Z","timestamp":1762642641991,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:00:00Z","timestamp":1647043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:00:00Z","timestamp":1647043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004336","name":"novartis","doi-asserted-by":"publisher","award":["1245578"],"award-info":[{"award-number":["1245578"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00277-022-04804-z","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T09:02:33Z","timestamp":1647075753000},"page":"991-997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Eltrombopag in pediatric chronic and refractory ITP: data from a retrospective multicenter study from Lebanon"],"prefix":"10.1007","volume":"101","author":[{"given":"Peter","family":"Noun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adlette","family":"Inati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Raffoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Abi","family":"Younes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Mardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Khalife","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,12]]},"reference":[{"key":"4804_CR1","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","volume":"358","author":"T Kuhne","year":"2001","unstructured":"Kuhne T, Imbach P, Bolton-Maggs PHB et al (2001) For the International Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 358:2122\u20132155","journal-title":"Lancet"},{"key":"4804_CR2","doi-asserted-by":"publisher","unstructured":"Al-Samkari H, Kuter DJ (2019) Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia. Ther Adv Hematol\u00a010:2040620719841735. https:\/\/doi.org\/10.1177\/2040620719841735","DOI":"10.1177\/2040620719841735"},{"issue":"8","key":"4804_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/pbc.26003","volume":"63","author":"C Neunert","year":"2016","unstructured":"Neunert C, Despotovic J, Haley K et al (2016) Pediatric ITP Consortium of North America (ICON). Thrombopoietin receptor agonist use in children: data from the Pediatric ITP Consortium of North America ICON2 Study. Pediatr Blood Cancer 63(8):1407\u201313","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"4804_CR4","first-page":"473","volume":"11","author":"I Cserhati","year":"1958","unstructured":"Cserhati I, Kelemen E (1958) Acute prolonged thrombocytosis in mice induced by thrombocythaemic sera; a possible human thrombopoietin; a preliminary communication. Acta Med Acad Sci Hung 11(4):473\u2013475","journal-title":"Acta Med Acad Sci Hung"},{"issue":"7","key":"4804_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/0092-8674(94)90450-2","volume":"77","author":"TD Bartley","year":"1994","unstructured":"Bartley TD, Bogenberger J, Hunt P et al (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77(7):1117\u20131124","journal-title":"Cell"},{"issue":"6481","key":"4804_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/369533a0","volume":"369","author":"FJ de Sauvage","year":"1994","unstructured":"de Sauvage FJ, Hass PE, Spencer SD et al (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369(6481):533\u2013538","journal-title":"Nature"},{"issue":"23","key":"4804_CR7","doi-asserted-by":"publisher","first-page":"11104","DOI":"10.1073\/pnas.91.23.11104","volume":"91","author":"DJ Kuter","year":"1994","unstructured":"Kuter DJ, Beeler DL, Rosenberg RD (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 91(23):11104\u201311108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"4804_CR8","doi-asserted-by":"publisher","first-page":"13023","DOI":"10.1073\/pnas.91.26.13023","volume":"91","author":"DC Foster","year":"1994","unstructured":"Foster DC, Sprecher CA, Grant FJ et al (1994) Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 91(26):13023\u201313027","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6481","key":"4804_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/369565a0","volume":"369","author":"S Lok","year":"1994","unstructured":"Lok S, Kaushansky K, Holly RD et al (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369(6481):565\u2013568","journal-title":"Nature"},{"issue":"9037","key":"4804_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(96)04471-6","volume":"348","author":"RL Basser","year":"1996","unstructured":"Basser RL, Rasko JE, Clarke K et al (1996) Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) in patients with advanced cancer. Lancet 348(9037):1279\u20131281","journal-title":"Lancet"},{"issue":"11","key":"4804_CR11","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1182\/blood.V94.11.3694","volume":"94","author":"E Archimbaud","year":"1999","unstructured":"Archimbaud E, Ottmann OG, Yin JA et al (1999) A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia. Blood 94(11):3694\u20133701","journal-title":"Blood"},{"issue":"5","key":"4804_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1182\/blood.V98.5.1339","volume":"98","author":"DJ Kuter","year":"2001","unstructured":"Kuter DJ, Goodnough LT, Romo J et al (2001) Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood 98(5):1339\u20131345","journal-title":"Blood"},{"issue":"8","key":"4804_CR13","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1182\/blood.V95.8.2530","volume":"95","author":"CA Schiffer","year":"2000","unstructured":"Schiffer CA, Miller K, Larson RA et al (2000) A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia. Blood 95(8):2530\u20132535","journal-title":"Blood"},{"issue":"8","key":"4804_CR14","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/S2352-3026(15)00114-3","volume":"2","author":"JB Bussel","year":"2015","unstructured":"Bussel JB, de Miguel PG, Despotovic JM et al (2015) Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. Lancet Haematol 2(8):e315\u2013e325","journal-title":"Lancet Haematol"},{"issue":"10004","key":"4804_CR15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(15)61107-2","volume":"386","author":"JD Grainger","year":"2015","unstructured":"Grainger JD, Locatelli F, Chotsampancharoen T et al (2015) Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet 386(10004):1649\u20131658","journal-title":"Lancet"},{"issue":"4","key":"4804_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/bloodadvances.2017010660","volume":"2","author":"TO Kim","year":"2018","unstructured":"Kim TO, Despotovic J, Lambert MP (2018) Eltrombopag for use in children with immune thrombocytopenia. Blood Adv 2(4):454\u2013461","journal-title":"Blood Adv"},{"issue":"11","key":"4804_CR17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393","journal-title":"Blood"},{"issue":"3","key":"4804_CR18","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1002\/ajh.23900","volume":"90","author":"TJ Gonz\u00e1lez-L\u00f3pez","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez TJ, Pascual C, \u00c1lvarez-Rom\u00e1n MT et al (2015) Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia. Am J Hematol 90(3):E40\u2013E43","journal-title":"Am J Hematol"},{"key":"4804_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fmed.2020.00066","volume":"7","author":"P Giordano","year":"2020","unstructured":"Giordano P, Lassandro G, Barone A et al (2020) Use of eltrombopag in children with chronic immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Front Med (Lausanne) 7:66. https:\/\/doi.org\/10.3389\/fmed.2020.00066 (eCollection 2020)","journal-title":"Front Med (Lausanne)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04804-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T09:07:27Z","timestamp":1649408847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04804-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,12]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4804"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04804-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2022,3,12]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors provided their consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}